Newron Pharmaceuticals
NWRN.SW
#8335
Rank
S$0.24 B
Marketcap
$12.66
Share price
1.45%
Change (1 day)
6.10%
Change (1 year)

Earnings for Newron Pharmaceuticals (NWRN.SW)

Earnings in 2023: -S$23.91 Million

According to Newron Pharmaceuticals's latest financial reports the company's current earnings are S$10.01 Million. In 2023 the company made an earning of -S$23.91 Million, an increase over its 2022 earnings that were of -S$25.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Newron Pharmaceuticals from 2005 to 2023

Annual earnings

Year Earnings Change
2023-S$23.91 Million-4.45%
2022-S$25.02 Million11.19%
2021-S$22.5 Million-30.14%
2020-S$32.21 Million6.84%
2019-S$30.15 Million31.45%
2018-S$22.94 Million170.13%
2017-S$8.49 Million-60.23%
2016-S$21.35 Million-41.46%
2015-S$36.47 Million109.46%
2014-S$17.41 Million22.43%
2013-S$14.22 Million222.49%
2012-S$4.41 Million-60.49%
2011-S$11.16 Million-71%
2010-S$38.48 Million-17.37%
2009-S$46.57 Million52.58%
2008-S$30.53 Million41.24%
2007-S$21.62 Million-25.19%
2006-S$28.89 Million22.45%
2005-S$23.6 Million